Skip to content

Anxiety: all studies

Page 347 of 769: studies 3,461 to 3,470 of 7,689, newest first. Back to the anxiety overview

Research

Esketamine Use in Treatment-Resistant Depression with Comorbid ADHD and Autistic Traits: A Case Report

European Psychiatry June 1, 2026 E. D. Cindik-Herbrueggen, A. S. Kucukali

Introduction Adult attention-deficit/hyperactivity disorder (ADHD) frequently co-occurs with mood and anxiety disorders (Sandstrom et al. Acta Psychiatr Scand 2021;143 380–391), and when major depressive disorder (MDD) is present, it often follows a treatment-resistant course (Thapar et al. J Child Psychol Psychiatry 2023;64 4–15). Intranasal esketamine, a non-competitive NMDA-receptor...

Psychedelic Renaissance: A New Paradigm in Mental Health

European Psychiatry June 1, 2026 A. M. Matas Ochoa, A. R. Quiroga, I. D. Sacristán

Introduction Psychedelics are hallucinogenic agents that are awakening scientific interest in recent years, especially in the field of mental health. Psychedelics induce non-ordinary states of consciousness and alterations in the emotions and in cognition and could be beneficial in treating some mental illness. Objectives The objective of the poster is to expand knowledge about emerging...

MM120 (Lysergide) May Enhance Neuroplasticity by Post-Dose Upregulation of TrkB

European Psychiatry June 1, 2026 G. Smagin, J. Tripp

Introduction MM120 (lysergide D-tartrate, a formulation of LSD) is under development as a potential treatment for generalized anxiety and major depressive disorders. How psychedelic drugs interact at the TrkB receptor, a key target of neuroplasticity, is not reported. Objectives The study evaluated binding and functional activity of known serotonergic psychedelic compounds and SRI fluoxetine at...

MDMA-Assisted Psychotherapy for Cluster B Personality Disorders: A Narrative Review of This Translational Framework for Relational Healing

European Psychiatry June 1, 2026 M. Rocha, V. Sharma, S. Prasad et al.

Introduction Psychedelic-assisted psychotherapy has re-emerged as a frontier of psychiatry, offering transformative potential for conditions resistant to conventional treatment. Personality disorders—particularly Borderline Personality Disorder (BPD)—are marked by affective instability, interpersonal dysfunction, and maladaptive relational patterns that often limit therapeutic progress. MDMA’s...

DOI: 10.1192/j.eurpsy.2026.11914 (opens in new tab) Full text (opens in new tab) Borderline personality disorder Openness to experience Interpersonal communication Narrative review +13

HEALTHY AGING THROUGH YOGA AND PRANAYAMA: A PREVENTIVE HEALTHCARE APPROACH

IIP Series June 1, 2026

The rapid growth of the elderly population has created a significant demand for preventive and holistic healthcare strategies that support healthy and independent living in later life. Aging is generally associated with gradual decline in physical efficiency, psychological resilience, respiratory function, cognitive performance, and social participation. In recent years, Yoga and Pranayama have...

Fears of compassion differentially relate to recognition of positive emotions in others after inductions of loving-kindness or muscle relaxation: a study among highly socially anxious young adults.

Cognition & Emotion June 1, 2026 Ashley N Howell, Audrey Darnbush

Social anxiety disorder (SAD) is characterised by heightened fears of negative and positive evaluation, which may contribute to deficits in emotion recognition and social functioning. This study examined the relationship between trait fears of compassion (FOCs) and accuracy in emotion recognition, following a brief Loving-Kindness Meditation (LKM) versus Progressive Muscle Relaxation (PMR)....

DOI: 10.1080/02699931.2025.2566303 (opens in new tab) Full text (opens in new tab) Fear of compassion Emotion recognition Loving-kindness Progressive muscle relaxation +1

An Exploratory Mixed-Methods Study on the Practice of Samatha-Vipassana in Agama Meditation and the Improvement of Physical and Mental States

International Journal of Social Science and Education Research June 1, 2026 Ven Dianwu

The "Samatha-Vipassana" practice of Agama meditation is considered to be able to deeply regulate the body and mind. However, there is still a lack of systematic exploratory research on its mechanism of action and group effects. This study adopted an exploratory mixed-methods design. In the quantitative part, a cross-sectional questionnaire survey was conducted on 509 regular practitioners to...

The influence of mindfulness therapy on NSSI and serum proBDNF in adolescents with depressive episode of depressive episode of bipolar disorder.

Psychiatry Research June 1, 2026 Peng Wang, Tong Wang, Yanling Wang et al.

There is a significant association between depressive episodes of bipolar disorder and non-suicidal self-injury (NSSI). Mindfulness-based cognitive therapy (MBCT) represents an evolution of cognitive behavioural therapy and serves as a comprehensive psychological intervention. Preliminary research suggests that MBCT may enhance cognitive flexibility and attentional adjustment in patients with...

Dream tyranny: Hyperonirism diagnostic criteria.

L'Encephale June 1, 2026 Pierre A Geoffroy, Sammy Saadi, Sibylle Mauries et al.

Hyperonirism, or "epic dreaming," is an emerging clinical phenomenon characterized by excessive, vivid, and continuous dream activity associated with non-restorative sleep and daytime fatigue. Despite historical descriptions, it remains poorly defined and unrecognized by current nosological systems. We describe four patients assessed in expert sleep and psychiatry centers, presenting with...

DOI: 10.1016/j.encep.2026.03.006 (opens in new tab) Full text (opens in new tab) Dream overflow Débordement onirique Epic dreaming Excessive dreaming +9

How to Fix a Bad Trip? Hallucinogen Persistent Perception Disorder Treatment in Review

BJPsych Open June 1, 2026 Aleeha Batool, Chaitanya Morey

Aims: Hallucinogen Persistent Perception Disorder (HPPD) is characterised by a recurrence of hallucinogen-induced perceptual symptoms after the cessation of hallucinogen use, leading to clinically significant impairment in functioning. It remains difficult to diagnose due to multiple comorbid diagnoses and poor understanding in psychiatry. For these reasons documented incidence also remains...